Conexiant’s news site is now MDSpire News. Learn more
Advertisement
Can PAP resume immediately after sinus surgery?
Patients restarting therapy within 1 day showed no statistically significant adjusted differences in sinonasal healing, bleeding, or patient-reported outcomes.
Clinical Scorecard: Can PAP Resume Immediately After Sinus Surgery?
At a Glance
Category
Detail
Condition
Clinical topic addressed by the source article: Can PAP resume immediately after sinus surgery?
Key Mechanisms
The study examined whether resuming PAP on postoperative day 0 or 1 was associated with postoperative endoscopic and sinonasal outcomes, sleep quality, epistaxis, or PAP-related complications.
Target Population
Patients or participants described in the source article.
Care Setting
Care setting described in the source article.
Key Highlights
In this prospective controlled study, adjusted analyses found no statistically significant association between early PAP resumption and worse endoscopic outcomes at either postoperative visit.
Sinonasal symptoms and sleep quality improved in both groups, with no statistically significant between-group differences in adjusted analyses.
No patients in the PAP group required medical management for epistaxis, and no PAP-related complications were reported.
The study was nonrandomized, had baseline group differences, and relied on self-reported PAP adherence; its sample size limited assessment of uncommon complications.
Guideline-Based Recommendations
Diagnosis
The study assessed endoscopic findings using Lund-Kennedy scores and sinonasal symptoms using the SNOT-22; it did not provide diagnostic recommendations.
Management
The study evaluated PAP resumption on postoperative day 0 or 1 in patients with OSA; it did not establish a general postoperative PAP guideline.
Monitoring & Follow-up
Study assessments included postoperative visits at 5 to 12 days and 18 to 31 days, with evaluation of endoscopic scores, SNOT-22, sleep quality, epistaxis, and PAP-related complications.
Risks
No PAP-related complications were reported, and adjusted analyses found no significant association between early PAP resumption and greater bleeding severity or need for medical intervention.
The relatively small sample limited assessment of uncommon complications; patients with skull base defects and those undergoing certain extensive procedures were excluded.
Patient & Prescribing Data
The study included 100 adults with chronic rhinosinusitis undergoing functional endoscopic sinus surgery: 49 with OSA who resumed PAP on postoperative day 0 or 1 and 51 without OSA.
Early PAP resumption was not independently associated with worse endoscopic or symptom outcomes in adjusted analyses. PAP adherence was self-reported, and OSA severity was not evaluated.
Clinical Best Practices
Interpret the findings in light of the nonrandomized design, baseline differences between groups, and incomplete data for selected variables.
Do not generalize the results to patients with skull base defects or those undergoing the excluded extensive procedures.
The study authors stated that the findings support the safety of early PAP use after functional endoscopic sinus surgery; the study did not establish a universal resumption protocol.
Higher annual oral corticosteroid exposure was associated with greater odds of systemic adverse events, with avascular bone necrosis and pneumonia showing dose-dependent associations with cumulative dose and osteoporosis associated with longer annual exposure duration.
